Tag Archives: patients

Algorithm Uses Individual Medical History to Predict Patient’s Chance of Survival in ICU

Researchers in Denmark have developed a new algorithm that predicts an individual patient’s risk of mortality in the ICU. Their work, recently published in the journal Digital Health, demonstrates that the algorithm outperforms current non-computational methods of estimating mortality. Algorithms of this nature can help direct resources where they are needed most to best improve… Read More »

FDA’s Project Facilitate Will Help Providers Access Experimental Cancer Therapies for Patients

FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer Today, the U.S. Food and Drug Administration Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved therapies for patients with cancer. A new call center called Project Facilitate will… Read More »

FDA Approves Revlimid (lenalidomide) In Combination with Rituximab for the Treatment of Adult Patients with Previously Treated Follicular Lymphoma or Marginal Zone Lymphoma

Print this page SUMMIT, N.J.–(BUSINESS WIRE) May 28, 2019 — Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) approved Revlimid (lenalidomide) in combination with a rituximab product (R²) for the treatment of adult patients with previously treated follicular lymphoma (FL) or marginal zone lymphoma (MZL) following Priority Review designation. This… Read More »